AU Patent

AU2017205168A1 — Methods for administering angiotensin II

Assigned to La Jolla Pharma LLC · Expires 2018-08-16 · 8y expired

What this patent protects

The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.

USPTO Abstract

The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017205168A1
Jurisdiction
AU
Classification
—
Expires
2018-08-16
Drug substance claim
No
Drug product claim
No
Assignee
La Jolla Pharma LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.